im not that worried, to be honest.
Anavex have moved the goalposts for their ph2/3 trial, not to mention all of the who-haw regarding their last phase results - meaning IMO once they get to FDA approval they will be scrutinized way more !
I see them on the backfoot trying to prove their worth, as opposed to NEU which has really played a "slow and steady" game.
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-69
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.14 |
Change
-0.130(0.85%) |
Mkt cap ! $1.935B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $7.335M | 485.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7079 | $15.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.17 | 3189 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |